Transcranial stimulation in frontotemporal dementia: A randomized, double‐blind, sham‐controlled trial
First published: 27 May 2020
Study funding: : This study was supported by funding from the Alzheimer's Drug Discovery Foundation (ADDF) (grant number #2017701) and the Italian Ministry of Health (Ricerca Corrente).
ClinicalTrials.gov identifier: : NCT02999282
Classification of Evidence: : This study provides Class II evidence that is effective and safe in FTD.
No hay comentarios:
Publicar un comentario